目錄:MedChemExpress LLC>>生化試劑>> SLV-2436 | MCE
參考價(jià) | 面議 |
參考價(jià) | 面議 |
更新時(shí)間:2023-06-19 09:14:23瀏覽次數(shù):134評(píng)價(jià)
聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息,謝謝!
CAS | 2095704-43-9 | 分子量 | 350.8 |
---|---|---|---|
分子式 | C??H??ClN?O | 供貨周期 | 現(xiàn)貨 |
規(guī)格 | 100 mg | 貨號(hào) | HY-112113 |
應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),,我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù),。
CAS No. : 2095704-43-9
產(chǎn)品活性:SLV-2436 is a highly potent and ATP-competitive inhibitor of MNK1 and MNK2 with IC50s of 10.8 ?nM and 5.4 nM, respectively.
研究領(lǐng)域:MAPK/ERK Pathway
作用靶點(diǎn):MNK
In Vitro: To confirm the kinome selectivity of SLV-2436 (SEL201), the broad KINOMEscan competitive binding assay is performed at 1 μM, which includes 450 distinct kinases. The observed binding profile for SLV-2436 is significantly concentrated in the CAMK family of kinases that comprises MNK1 and MNK2. SLV-2436-treated KIT-mutant melanoma cells have lower oncogenicity and reduced metastatic ability.
In Vivo: To investigate the pharmacodynamic properties of SLV-2436 (SEL201), 5 consecutive oral doses of 10, 25, and 50 mg/kg are administered to mice every 12 hours (twice-daily schedule). At the 10 mg/kg twice-daily dosage, 4 hours after the fifth administration, a low plasma concentration of 125 ng/mL SLV-2436 is determined. However, dosing at 25 and 50 mg/kg twice daily, equivalent to 50 and 100 mg/kg/d of SLV-2436, yields substantially increased dose-dependent plasma exposure, reaching an average level of 1,299 ng/mL and 2,075 ng/mL, respectively. At the 24-hour time point, SLV-2436 is still detectable in the plasma, with dose-dependent concentrations of 9, 73, and 124 ng/mL in the 10, 25, and 50 mg/kg twice-daily treatment groups. Oral (p.o.) administration of SLV-2436 at the dosage of 50 mg/kg twice daily, that is, 100 mg/kg/d, for 37 days is well tolerated in mice.
相關(guān)產(chǎn)品:QL-X-138 | Cercosporamide | DS12881479 | MNK1/2-IN-5 | K783-0308 | MNK1/2-IN-6 | Tomivosertib | CGP 57380 | Tinodasertib | MNK inhibitor 9 | HG-10-102-01 | EB1
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物 | 寡核苷酸 | 抗體 | 點(diǎn)擊化學(xué)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,,我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物,;
• 50,000 多種高選擇性抑制劑,、激動(dòng)劑涉及各熱門信號(hào)通路及疾病領(lǐng),;
• 產(chǎn)品種類涵蓋各種重組蛋白,,多肽,,常用試劑盒 ,,更有 PROTAC、ADC 等特色產(chǎn)品,,廣泛應(yīng)用于新藥研發(fā),、生命科學(xué)等科研項(xiàng)目;
• 提供虛擬篩選,,離子通道篩選,,代謝組學(xué)分析檢測(cè)分析,藥物篩選等專業(yè)技術(shù)服務(wù),;
• 設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控,、驗(yàn)證體系,;
• 提供 LC/MS、NMR,、HPLC,、手性分析、元素分析等各項(xiàng)質(zhì)檢報(bào)告,,確保產(chǎn)品的高純度,、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實(shí)驗(yàn)驗(yàn)證,;
• Nature, Cell, Science 等多種頂級(jí)期刊及制藥 Patent 收錄了MCE客戶的科研成果,;
• 專業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展,為您提供*新的活性化合物,;
• 與世界各大制藥公司及著名科研機(jī)構(gòu)建立了長期的合作,。
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)